. 2021 Mar 4;10(3):295. doi: 10.3390/pathogens10030295

Table 3.

Eligibility criteria.

Eligibility Criteria
Population: Infertile woman attending IVF-treatment, all causes. Following methods were emphasized, when investigating on the vaginal microbiota (exposure): Microscopy, PCR technology, Fluorescence In Situ Hybridization (FISH) and Next Generation Sequencing. Outcomes: Studies reporting on one of the critical or important outcomes. Human studies only. Primary research article only. English language only. Cut off year 1980 Sub-Saharan African studies were excluded due to a higher background prevalence of competitive co-infections with BV, e.g., HIV, Trichomonas vaginalis and Chlamydia trachomatis. Case reports and Reviews were excluded.

Eligibility Criteria

Population: Infertile woman attending IVF-treatment, all causes.
Following methods were emphasized, when investigating on the vaginal microbiota (exposure): Microscopy, PCR technology, Fluorescence In Situ Hybridization (FISH) and Next Generation Sequencing.
Outcomes: Studies reporting on one of the critical or important outcomes.
Human studies only.
Primary research article only.
English language only.
Cut off year 1980
Sub-Saharan African studies were excluded due to a higher background prevalence of competitive co-infections with BV, e.g., HIV, Trichomonas vaginalis and Chlamydia trachomatis.
Case reports and Reviews were excluded.